Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-166872
Filing Date
2023-06-14
Accepted
2023-06-14 16:16:28
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d483990ds3.htm S-3 146861
2 EX-5.1 d483990dex51.htm EX-5.1 7915
3 EX-23.2 d483990dex232.htm EX-23.2 1692
4 EX-FILING FEES d483990dexfilingfees.htm EX-FILING FEES 17624
5 GRAPHIC g483990g00a01.jpg GRAPHIC 40579
6 GRAPHIC g483990g0613105018121.jpg GRAPHIC 4537
  Complete submission text file 0001193125-23-166872.txt   233330
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-272641 | Film No.: 231014317
SIC: 2835 In Vitro & In Vivo Diagnostic Substances